Wegovy 1 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FH3E8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,259
Award facts
- Contract value 100% obligated
- $14,259.14 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $14,259.14 to AmerisourceBergen Drug Corp for the supply of Wegovy 1 mg/0.5 ml pen injections (0.5 ml) with an ultimate completion date of September 26, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement supporting the federal government's medical supply needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The order will be performed at the company's corporate office location in Conshohocken, PA 19428.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical prime vendor agreement valued at $999,999,999.00 and extending through December 2026. This global contract vehicle enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, and vaccines. The delivery order for Wegovy, a GLP-1 receptor agonist used in diabetes and weight management treatment, aligns with the company's extensive portfolio of therapeutic medications supplied across federal healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FH3E8?
SPE2DB25FH3E8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 25, 2025.
How much is contract SPE2DB25FH3E8 worth?
The government has obligated $14,259 on SPE2DB25FH3E8.
Is contract SPE2DB25FH3E8 an order under another contract?
Yes. SPE2DB25FH3E8 is a delivery order under SPE2DB22D1103, an indefinite delivery contract.
Was contract SPE2DB25FH3E8 competed?
The extent of competition for SPE2DB25FH3E8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award